Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Reconstitute at 0.2 mg/mL in sterile PBS.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Plexin B1 Antibody [Unconjugated]
Transmembrane Protein SEP
Plexin B1 is a type I transmembrane protein that belongs to the Plexin
family of semaphorin receptors. It is derived from a single peptide
that undergoes proteolytic processing in its extracellular domain to
form the non-covalently-linked heterodimer of the extracellular alpha
subunit and the transmembrane beta subunit. Human Plexin B1 extracellular
alpha subunit shares homology with semaphorins, HGF receptor and MSP
receptor and contains a sema domain and three IPT/TIG domains. It
functions as a receptor for semaphorin 4D/CD100. Multiple splice
isoforms of Plexin B1 have been reported. Within the region used as
immunogen, human Plexin B1 shares 90% and 97% amino acid sequence
homology with mouse and canine Plexin B1, respectively.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our Plexin B1 Antibody [Unconjugated] and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.